GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » U2Bio Co Ltd (XKRX:221800) » Definitions » EBITDA Margin %

U2Bio Co (XKRX:221800) EBITDA Margin % : -5.44% (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is U2Bio Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. U2Bio Co's EBITDA for the six months ended in Dec. 2023 was ₩-756 Mil. U2Bio Co's Revenue for the six months ended in Dec. 2023 was ₩13,904 Mil. Therefore, U2Bio Co's EBITDA margin for the quarter that ended in Dec. 2023 was -5.44%.


U2Bio Co EBITDA Margin % Historical Data

The historical data trend for U2Bio Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U2Bio Co EBITDA Margin % Chart

U2Bio Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only 7.08 3.81 19.29 24.69 3.23

U2Bio Co Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
EBITDA Margin % 34.52 1.16 10.36 -5.44

Competitive Comparison of U2Bio Co's EBITDA Margin %

For the Diagnostics & Research subindustry, U2Bio Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


U2Bio Co's EBITDA Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, U2Bio Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where U2Bio Co's EBITDA Margin % falls into.



U2Bio Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

U2Bio Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=993.337/30792.037
=3.23 %

U2Bio Co's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-756.262/13904.222
=-5.44 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


U2Bio Co  (XKRX:221800) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


U2Bio Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of U2Bio Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


U2Bio Co (XKRX:221800) Business Description

Traded in Other Exchanges
N/A
Address
Basement 1, 68 Gumaro Songpagu, Seoul, KOR
U2Bio Co Ltd provides vitro diagnostic test services. The company is engaged in offering general diagnostic tests, molecular diagnostic tests, and breastfeeding nutritional analysis services among others.

U2Bio Co (XKRX:221800) Headlines

No Headlines